CAP antibiotics

• related: community acquired pneumonia, pneumonia vaccine

• Outpatient:
  • Healthy: amoxicillin || doxycycline || macrolide
  • comorbidities: oral b-lactam plus macrolide/doxy || respiratory fluoroquinolone
• Inpatient: IV b-lactam plus macrolide || respiratory fluoroquinolone
• ICU: IV b-lactam plus macrolide || B-lactam plus respiratory fluoroquinolone
• risk of pseudomonas:

pneumonia severity index

• related: community acquired pneumonia

The Pneumonia Severity Index (PSI) is a validated predictor of all-cause mortality at 30 days. The initial assessment determines the presence of 11 variables associated with adverse outcomes. Patients with no risk factors (severity risk class I) can typically be managed as outpatients. Those with at least one risk factor are stratified using a second scoring system into a risk classification between II

pneumonia vaccine

• related: community acquired pneumonia

• More than 65: 13 => 23
• Less than 65:
  • Immune suppressed/asplenic: 13 => 23
  • Not immune suppressed:
    • Healthy: no vaccine
    • Chronic disease: 23 => 13 => 23

The dashed line represents the interval between the two PPSV23 doses. PCV13 = 13-valent pneumococcal conjugate vaccine